GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (OTCPK:NONOF) » Definitions » Other Long Term Assets

NONOF (Novo Nordisk AS) Other Long Term Assets : $3,857 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Novo Nordisk AS Other Long Term Assets?

Novo Nordisk AS's other long-term assets for the quarter that ended in Sep. 2024 was $3,857 Mil.

Novo Nordisk AS's quarterly other long-term assets increased from Mar. 2024 ($3,350 Mil) to Jun. 2024 ($3,569 Mil) and increased from Jun. 2024 ($3,569 Mil) to Sep. 2024 ($3,857 Mil).

Novo Nordisk AS's annual other long-term assets increased from Dec. 2021 ($1,358 Mil) to Dec. 2022 ($2,009 Mil) and increased from Dec. 2022 ($2,009 Mil) to Dec. 2023 ($3,191 Mil).

Novo Nordisk AS Other Long Term Assets Historical Data

The historical data trend for Novo Nordisk AS's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Other Long Term Assets Chart

Novo Nordisk AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 738.07 1,069.27 1,358.31 2,009.14 3,191.02

Novo Nordisk AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,753.98 3,191.02 3,349.81 3,568.56 3,857.40

Novo Nordisk AS Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Novo Nordisk AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (OTCPK:NONOF) » Definitions » Other Long Term Assets
Comparable Companies
XSWX:SGKN XSWX:SREN XSWX:WKBN XSWX:MOZN XSWX:GMI XSWX:LLBN XSWX:BEKN XSWX:ASWN XSWX:BELL XSWX:EFGN LLY JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE XPAR:SAN
Traded in Other Exchanges
NVO:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NOV:Bulgaria NNO2:Austria
Address
Novo Alle 1, Bagsvaerd, DNK, 2880
Website
https://www.novonordisk.com
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.